N/A
N=201
Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification
Healthy Volunteers
Bottom Line
View on ClinicalTrials.gov: NCT01821534 ↗Enrolled (actual)
201
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcome: Primary: Inter-rater Reliability Using a Masseter Muscle Prominence Scale (MMPS) — 0.728; 0.711 Kendall's W
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- No Intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- May 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Inter-rater Reliability Using a Masseter Muscle Prominence Scale (MMPS) |
0.728; 0.711 | — |
| PRIMARY Intra-rater Reliability Using a MMPS |
0.634; 0.638 | — |
| PRIMARY Inter-rater Reliability Using a Lower Facial Shape Classification (LFSC) |
0.358; 0.352 | — |
| PRIMARY Intra-rater Reliability Using a LFSC |
0.658 | — |
Summary
This study will evaluate the inter-rater and intra-rater reliability of a Masseter Muscle Prominence Scale for evaluating a patient's muscle prominence and a Lower Shape Classification for evaluating a patient's lower facial shape.
Eligibility Criteria
Inclusion Criteria
-sufficient visual acuity without the use of glasses or with contact lenses to self-assess lower facial shape in a mirror
Exclusion Criteria
- infection of the mouth or gums, or facial skin infection requiring antibiotics
- planned dental or facial procedure
- unwillingness to be photographed and have the photos used for research, training, or educational purposes
Data sourced from ClinicalTrials.gov (NCT01821534). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.